XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Convertible Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Total
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2022 $ (44,201)     $ 3 $ 6,552   $ (50,756)
Beginning Balance (in shares) at Dec. 31, 2022       3,181,829      
Temporary Equity, Beginning Balance at Dec. 31, 2022   $ 74,694          
Temporary Equity, Beginning Balance (in shares) at Dec. 31, 2022   75,000,000          
Vesting of restricted common stock 6       6    
Stock-based compensation expense 343       343    
Net loss (9,171)           (9,171)
Ending Balance at Mar. 31, 2023 (53,023)     $ 3 6,901   (59,927)
Ending Balance (in shares) at Mar. 31, 2023       3,181,829      
Temporary Equity, Ending Balance at Mar. 31, 2023   $ 74,694          
Temporary Equity, Ending Balance (in shares) at Mar. 31, 2023   75,000,000          
Beginning Balance at Dec. 31, 2022 (44,201)     $ 3 6,552   (50,756)
Beginning Balance (in shares) at Dec. 31, 2022       3,181,829      
Temporary Equity, Beginning Balance at Dec. 31, 2022   $ 74,694          
Temporary Equity, Beginning Balance (in shares) at Dec. 31, 2022   75,000,000          
Net loss (30,714)            
Ending Balance at Sep. 30, 2023 (73,849)     $ 3 7,618   (81,470)
Ending Balance (in shares) at Sep. 30, 2023       3,168,134      
Temporary Equity, Ending Balance at Sep. 30, 2023   $ 74,694 $ 74,521        
Temporary Equity, Ending Balance (in shares) at Sep. 30, 2023   75,000,000 60,828,720        
Beginning Balance at Mar. 31, 2023 (53,023)     $ 3 6,901   (59,927)
Beginning Balance (in shares) at Mar. 31, 2023       3,181,829      
Temporary Equity, Beginning Balance at Mar. 31, 2023   $ 74,694          
Temporary Equity, Beginning Balance (in shares) at Mar. 31, 2023   75,000,000          
Issuance of Series B Convertible Preferred Stock, issuance costs     $ 72,021        
Issuance of Series B Convertible Preferred Stock, issuance costs (in shares)     58,801,098        
Vesting of restricted common stock 9       9    
Repurchase of unvested restricted common stock (in shares)       (2,807)      
Stock-based compensation expense 355       355    
Net loss (10,598)           (10,598)
Ending Balance at Jun. 30, 2023 (63,257)     $ 3 7,265   (70,525)
Ending Balance (in shares) at Jun. 30, 2023       3,179,022      
Temporary Equity, Ending Balance at Jun. 30, 2023   $ 74,694 $ 72,021        
Temporary Equity, Ending Balance (in shares) at Jun. 30, 2023   75,000,000 58,801,098        
Issuance of Series B Convertible Preferred Stock, issuance costs     $ 2,500        
Issuance of Series B Convertible Preferred Stock, issuance costs (in shares)     2,027,622        
Vesting of restricted common stock 6       6    
Repurchase of unvested restricted common stock (in shares)       (10,888)      
Stock-based compensation expense 347       347    
Net loss (10,945)           (10,945)
Ending Balance at Sep. 30, 2023 (73,849)     $ 3 7,618   (81,470)
Ending Balance (in shares) at Sep. 30, 2023       3,168,134      
Temporary Equity, Ending Balance at Sep. 30, 2023   $ 74,694 $ 74,521        
Temporary Equity, Ending Balance (in shares) at Sep. 30, 2023   75,000,000 60,828,720        
Beginning Balance at Dec. 31, 2023 (38,374)     $ 3 8,199   (46,576)
Beginning Balance (in shares) at Dec. 31, 2023       3,168,134      
Temporary Equity, Beginning Balance at Dec. 31, 2023 149,215 $ 74,694 $ 74,521        
Temporary Equity, Beginning Balance (in shares) at Dec. 31, 2023   75,000,000 60,828,720        
Issuance of common stock upon exercise of stock options 1       1    
Issuance of common stock upon exercise of stock options (in shares)       217      
Vesting of restricted common stock 6       6    
Repurchase of unvested restricted common stock (in shares)       (11,517)      
Stock-based compensation expense 577       577    
Net unrealized gain (loss) on available-for-sale marketable securities (7)         $ (7)  
Net loss (14,097)           (14,097)
Ending Balance at Mar. 31, 2024 (51,894)     $ 3 8,783 (7) (60,673)
Ending Balance (in shares) at Mar. 31, 2024       3,156,834      
Temporary Equity, Ending Balance at Mar. 31, 2024   $ 74,694 $ 74,521        
Temporary Equity, Ending Balance (in shares) at Mar. 31, 2024   75,000,000 60,828,720        
Beginning Balance at Dec. 31, 2023 (38,374)     $ 3 8,199   (46,576)
Beginning Balance (in shares) at Dec. 31, 2023       3,168,134      
Temporary Equity, Beginning Balance at Dec. 31, 2023 149,215 $ 74,694 $ 74,521        
Temporary Equity, Beginning Balance (in shares) at Dec. 31, 2023   75,000,000 60,828,720        
Net loss (51,130)            
Ending Balance at Sep. 30, 2024 (87,408)     $ 3 10,119 176 (97,706)
Ending Balance (in shares) at Sep. 30, 2024       3,162,968      
Temporary Equity, Ending Balance at Sep. 30, 2024 224,157 $ 74,694 $ 149,463        
Temporary Equity, Ending Balance (in shares) at Sep. 30, 2024   75,000,000 121,657,452        
Beginning Balance at Mar. 31, 2024 (51,894)     $ 3 8,783 (7) (60,673)
Beginning Balance (in shares) at Mar. 31, 2024       3,156,834      
Temporary Equity, Beginning Balance at Mar. 31, 2024   $ 74,694 $ 74,521        
Temporary Equity, Beginning Balance (in shares) at Mar. 31, 2024   75,000,000 60,828,720        
Issuance of Series B Convertible Preferred Stock, issuance costs     $ 74,942        
Issuance of Series B Convertible Preferred Stock, issuance costs (in shares)     60,828,732        
Issuance of common stock upon exercise of stock options 10       10    
Issuance of common stock upon exercise of stock options (in shares)       6,186      
Vesting of restricted common stock 4       4    
Stock-based compensation expense 628       628    
Net unrealized gain (loss) on available-for-sale marketable securities (1)         (1)  
Net loss (16,510)           (16,510)
Ending Balance at Jun. 30, 2024 (67,763)     $ 3 9,425 (8) (77,183)
Ending Balance (in shares) at Jun. 30, 2024       3,163,020      
Temporary Equity, Ending Balance at Jun. 30, 2024   $ 74,694 $ 149,463        
Temporary Equity, Ending Balance (in shares) at Jun. 30, 2024   75,000,000 121,657,452        
Issuance of common stock upon exercise of stock options 5       5    
Issuance of common stock upon exercise of stock options (in shares)       2,730      
Vesting of restricted common stock 6       6    
Repurchase of unvested restricted common stock (in shares)       (2,782)      
Stock-based compensation expense 683       683    
Net unrealized gain (loss) on available-for-sale marketable securities 184         184  
Net loss (20,523)           (20,523)
Ending Balance at Sep. 30, 2024 (87,408)     $ 3 $ 10,119 $ 176 $ (97,706)
Ending Balance (in shares) at Sep. 30, 2024       3,162,968      
Temporary Equity, Ending Balance at Sep. 30, 2024 $ 224,157 $ 74,694 $ 149,463        
Temporary Equity, Ending Balance (in shares) at Sep. 30, 2024   75,000,000 121,657,452